Autophagy promotion enhances the protective effect of Morroniside on human OA chondrocyte.
Aged
Apoptosis
/ drug effects
Autophagy
/ drug effects
Autophagy-Related Protein 5
/ genetics
Autophagy-Related Protein 7
/ genetics
Beclin-1
/ genetics
Cartilage, Articular
/ pathology
Cell Proliferation
/ drug effects
Cells, Cultured
Chondrocytes
/ drug effects
Female
Glycosides
/ pharmacology
Humans
Male
Middle Aged
Osteoarthritis, Knee
/ metabolism
Phosphatidylinositol 3-Kinases
/ metabolism
Protective Agents
/ pharmacology
Signal Transduction
/ drug effects
TOR Serine-Threonine Kinases
/ metabolism
Transduction, Genetic
Up-Regulation
/ drug effects
Morroniside
autophagy
chondrocyte
mTOR
osteoarthritis
Journal
Bioscience, biotechnology, and biochemistry
ISSN: 1347-6947
Titre abrégé: Biosci Biotechnol Biochem
Pays: England
ID NLM: 9205717
Informations de publication
Date de publication:
May 2020
May 2020
Historique:
pubmed:
28
1
2020
medline:
8
1
2021
entrez:
28
1
2020
Statut:
ppublish
Résumé
Morroniside plays a therapeutic role in knee osteoarthritis (OA) by protecting chondrocytes. PI3K/AKT signaling is involved in the regulation of chondrocytes by Morroniside. PI3K/AKT suppresses autophagy through downstream signaling. However, the regulation of chondrocyte autophagy by Morroniside and the significance of the above effect on protecting chondrocytes aren't clear. The results showed that Morroniside inhibited the autophagiy of human OA chondrocytes. Besides, both PI3K inhibitors and mTOR inhibitors significantly reversed the autophagy reduced by Morroniside, but had no effect on the protective effect of Morroniside on chondrocytes. However, the enhanced autophagy caused by overexpression of autophagic genes enhanced the protective effect of Morroniside on chondrocytes. In conclusion, Morroniside represses the autophagy of human OA chondrocyte, which is related to PI3K/mTOR pathway. Moreover, the upregulation of autophagy further promoted the role of Morroniside in treating chondrocytes. Our data present a potential clue for the therapeutic strategies of Morroniside in treating OA.
Identifiants
pubmed: 31983285
doi: 10.1080/09168451.2020.1717925
doi:
Substances chimiques
ATG5 protein, human
0
Autophagy-Related Protein 5
0
BECN1 protein, human
0
Beclin-1
0
Glycosides
0
Protective Agents
0
morroniside
0
MTOR protein, human
EC 2.7.1.1
TOR Serine-Threonine Kinases
EC 2.7.11.1
ATG7 protein, human
EC 6.2.1.45
Autophagy-Related Protein 7
EC 6.2.1.45
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM